A pH-Dependent Kinetic Model of Dihydrolipoamide Dehydrogenase from Multiple Organisms  by Moxley, Michael A. et al.
Biophysical Journal Volume 107 December 2014 2993–3007 2993ArticleA pH-Dependent Kinetic Model of Dihydrolipoamide Dehydrogenase from
Multiple OrganismsMichael A. Moxley,1 Daniel A. Beard,2,* and Jason N. Bazil2
1Department of Biochemistry, Biotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee, Wisconsin; and
2Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MichiganABSTRACT Dihydrolipoamide dehydrogenase is a flavoenzyme that reversibly catalyzes the oxidation of reduced lipoyl sub-
strates with the reduction of NADþ to NADH. In vivo, the dihydrolipoamide dehydrogenase component (E3) is associated with
the pyruvate, a-ketoglutarate, and glycine dehydrogenase complexes. The pyruvate dehydrogenase (PDH) complex connects
the glycolytic flux to the tricarboxylic acid cycle and is central to the regulation of primary metabolism. Regulation of PDH via
regulation of the E3 component by the NADþ/NADH ratio represents one of the important physiological control mechanisms
of PDH activity. Furthermore, previous experiments with the isolated E3 component have demonstrated the importance of
pH in dictating NADþ/NADH ratio effects on enzymatic activity. Here, we show that a three-state mechanism that represents
the major redox states of the enzyme and includes a detailed representation of the active-site chemistry constrained by both
equilibrium and thermodynamic loop constraints can be used to model regulatory NADþ/NADH ratio and pH effects demon-
strated in progress-curve and initial-velocity data sets from rat, human, Escherichia coli, and spinach enzymes. Global fitting
of the model provides stable predictions to the steady-state distributions of enzyme redox states as a function of lipoamide/
dihydrolipoamide, NADþ/NADH, and pH. These distributions were calculated using physiological NADþ/NADH ratios represen-
tative of the diverse organismal sources of E3 analyzed in this study. This mechanistically detailed, thermodynamically con-
strained, pH-dependent model of E3 provides a stable platform on which to accurately model multicomponent enzyme
complexes that implement E3 from a variety of organisms.INTRODUCTIONDihydrolipoamide dehydrogenase (EC 1.8.1.4) is a member
of the disulfide oxidoreductase family and reversibly cata-
lyzes the oxidation of dihydrolipoamide with the reduction
of NADþ (1–4) using a flavin adenine dinucleotide (FAD)
cofactor.
Dihydrolipoamideþ NADþ#Lipoamideþ NADHþ Hþ
(1)
Dihydrolipoamide dehydrogenase (E3) is a component
of three different catabolic multienzyme complexes that
oxidize pyruvate, a-ketoglutarate, or glycine, where E3 cat-
alyzes the final step in a sequence of oxidative reactions (5).
Of these, the pyruvate dehydrogenase (PDH) complex is at
the interface of glycolysis and the tricarboxylic acid cycle
and is key in switching between the use of glucose or fatty
acids as the preferred substrate in skeletal muscle and heart
(6,7). The balance between glucose and fatty acid oxidation
is critical in the prevention of lipotoxicity which can lead to
hypertrophy in heart muscle and/or a diabetic state in skel-
etal muscle (6,8). The PDH complex communicates be-Submitted March 24, 2014, and accepted for publication September 24,
2014.
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substrates and products such as acetyl-CoA and the
NADþ/NADH ratio (9,10). The intracellular NADþ/
NADH ratio contributes to the activation/inhibition of the
complex by affecting E3 activity, most severely in Escheri-
chia coli (11,12) and plants (13), while also influencing
regulation of PDH-specific kinase and phosphatase activity
in mammals (14–16). The NADþ/NADH ratio is sensed
directly through the E3 component of the PDH complex,
so a detailed model that can predict E3 kinetic behavior
as a function of lipoamide/dihydrolipoamide (Lipo/DHL),
NADþ/NADH, and pH would be useful for predicting sub-
sequent effects on the complex and on glycolytic/lipolytic
balance (17,18).
In the physiological direction, dihydrolipoamide, which
is covalently tethered to another enzymatic subunit in the
multienzyme complex (5), binds to the disulfide-exchange
site near the si face of the FAD cofactor (4). Here, dihydro-
lipoamide is thought to donate a hydride to the disulfide and
a proton to an active-site base forming a stable charge-trans-
fer complex between the thiolate of the mixed disulfide and
the oxidized FAD cofactor (1,19,20). In the presence of
NADþ, electrons are passed to FAD and then to NADþ on
the re face of the flavin, forming NADH with the release
of a proton (21). Thus, the mechanism is carried out betweenhttp://dx.doi.org/10.1016/j.bpj.2014.09.025
2994 Moxley et al.two substrate/product binding sites that are mediated by
both sides of the FAD cofactor (4).
The E3 kinetic mechanism was first discussed by
Massey, who concluded, from a parallel line pattern
observed using Lineweaver-Burk plot analysis (LB) (1),
that the enzyme from pig heart displays ping-pong-type
kinetics. A ping-pong-type reaction was further con-
firmed using stopped-flow spectroscopy, which showed
that the overall reaction sequence can be broken into
reductive and oxidative half-reactions in the absence of
the other substrate (1,20,21). A more extensive study
employing initial velocity and product inhibition was car-
ried out with rat liver E3 and yielded product-inhibition
patterns that deviated from a simple one-site ping-pong
mechanism (22).
Interestingly, early studies of E3 from E. coli (3), spinach
(13), human liver (23), and pig heart (24) demonstrated an
activating effect of NADþ on the reverse reaction. It was
also observed that initial NADþ concentration could alter
the pH dependence (11,13,25). It was hypothesized that
the enzyme was being driven into a four-electron-reduced
state (2e reduced mixed disulfide and 2e reduced FAD),
which is considered to be a dead-end state (11,26). The
propensity to be regulated by this state is organism-specific.
For instance, E. coli E3 displays a greater sensitivity to
NADþ/NADH for the reverse reaction than do the pig heart
and human liver enzymes (11,23,26). It is believed that an
over-reduced E3 component is involved in regulating the
overall activity of PDH, and thus having a metabolic regu-
latory impact (3,17). The four-electron-reduced state not
only ties up the complex in a simple dead-end state but
may also increase the probability of down-regulation of
the complex via phosphorylation of the pyruvate dehydroge-
nase component (E1). This can occur by reducing lipoamide
moieties in the E2 component (dihydrolipoyl acetyltransfer-
ase), which then increases the affinity of PDH kinase bind-
ing (27–29).
Our main objective was to create a single model
that synthesizes the pH-dependent kinetics of E3 ob-
served from multiple organisms. Previous models do not
account for pH, which is a crucial factor in the regula-
tion of this enzyme and dictates the magnitude of the
NADþ/NADH effect on activity (11,22). Overall, we pro-
pose to our knowledge a new mechanism that is random
and rapid in the extent of substrate and product binding
and includes the reactions needed to produce and reverse
a four-electron-reduced dead-end state. Our model incorpo-
rates pH such that a proton binds randomly and is
treated much like a product in the overall reaction, as a
proton is produced in the forward direction. In addition,
the protonation states of both the active-site thiolate and
base are considered based on their importance in catalysis
(20,26,30).
The model explains initial velocity patterns in the pres-
ence and absence of products, shifts in pH-dependent veloc-Biophysical Journal 107(12) 2993–3007ity profiles as a function of NADþ, and observations of a lag
in progress curve data as a function of NADþ and pH. The
model not only can describe these phenomena but is simul-
taneously consistent with a detailed representation of the
enzyme active site proposed in a number of studies using
thermodynamic constraints (31).METHODS
Model overview
E3 can exist in one of four redox states (Fig. 1 A), including an oxidized
state (S1), a two-electron-reduced charge-transfer complex (S2) or a two-
electron-reduced FAD cofactor (S3) state, and a four-electron-reduced
dead-end state (S4). The mechanism advances through these major redox
states depending on the availability of substrates, products, and pH. Our
model treats substrate/product binding to be random and in rapid equilib-
rium at two independent sites for Lipo/DHL (site a) and NAD/NADH
(site b) (Fig. 1 B).
In the forward direction (Fig. 1 A), a two-electron reduction of the
enzyme from dihydrolipoamide results in a stable charge-transfer complex
(S1 to S2) where an active-site base (Enz-B:), typically a histidine residue
(4,30), is thought to accept a proton from dihydrolipoamide that is critical
for stabilizing the charge-transfer complex (20,26). Electrons pass to the
FAD cofactor, creating S3, which is then oxidized to S1 in the presence
of NADþ. The model accounts for the possibility of turnover occurring
through a ternary or ping-pong mechanism (32). A four-electron-reduced
dead-end state (S4) is produced from either of the two-electron-reduced
states by pH-modulated reduction of S2 by NADH or of S3 by
dihydrolipoamide.
A four-state model (Fig. 1 A) that distinguishes between the charge-
transfer complex (S2) and hydride-reduced FAD (S3) states in the
two-electron-reduced enzyme was simplified by creating a lumped
two-electron-reduced state (Fig. 1 C, S2,3). This simplification was
made based on the fact that the hydride transfer from the mixed
dithiol to the FAD cofactor has not been observed spectroscopically
except in the Mycobacterium enzyme (21,33). Moreover, a four-state
model is not necessary to fit the data. The protonation state of the
two-electron-reduced enzyme (Fig. 1 D) is critical in stabilizing
hydride transfer between the disulfide and FAD sites. It is believed
that hydride transfer can occur only when the active-site base is proton-
ated (Enz-BH) and the thiolate is deprotonated (Enz-S:), so that the
charge-transfer complex (Fig. 1 D, middle) between the thiolate and
oxidized FAD is stabilized (19,26,30). These active-site details were
incorporated into the model to more accurately describe the pH regula-
tion of catalysis.Model derivation
As shown previously, the fraction of each enzyme state occupied by sub-
strates, products, and protons can be quantified by fractional occupancies
(34,35). In a general manner, assuming rapid equilibrium binding, we
derived binding polynomials (Eq. 2) for dihydrolipoamide (A) and lipoa-
mide (P) binding to site a and for NADþ (B) and NADH (Q) binding
to site b to either the oxidized (1), two-electron-reduced (2,3), or four-
electron-reduced (4) enzyme species. Therefore, according to our nomen-
clature, D1a is the polynomial for binding of dihydrolipoamide and
lipoamide to site a of the oxidized enzyme state (S1), whereas D2,3a dif-
fers in that it determines the binding of these substrates to the two-elec-
tron-reduced enzyme state (S2,3). Accordingly, KA1 and KP1 represent
the equilibrium dissociation constants for dihydrolipoamide and lipoa-
mide, respectively, to the oxidized enzyme state (S1). Thus, our most gen-
eral model accounts for possible differences in substrate and product
FIGURE 1 (A) A four-state mechanism with
rapid equilibrium binding of substrates and
products, where S1, S2, S3, and S4 represent the
oxidized, two-electron-reduced charge-transfer
intermediate, hydride-reduced FAD, and four-
electron-reduced dead-end states, respectively.
Dihydrolipoamide, NADþ, lipoamide, NADH,
and a proton are represented by A, B, P, Q, and
Hþ, respectively. The fraction of each enzyme
state bound to substrate or product is represented
by f, subscript and superscript letters indicate
the chemical species that is bound, and subscript
numbers indicate the enzyme state. (B) Substrates
and products are considered to randomly bind
to either of two sites (a or b) and are in
rapid equilibrium with each major state indi-
cated by equilibrium dissociation constants of
the corresponding substrates. As discussed in
the main text, the added complexity of allow-
ing the equilibrium dissociation constants for
substrates and products to vary for each redox
state of the enzyme was invoked to improve
fits for certain data sets. (C) The mechanism
shown in A was simplified to three states so
that the two-electron-reduced states (S2 and S3
in A) are grouped into one state (S2,3), according
to previous observations that this step occurs very quickly (21,33). (D) Proton binding sites on the thiolate (S:) and active-site base (B:), typi-
cally a histidine residue (4,30), are modeled to further dictate whether certain substrate or product bound species can execute a chemical step in the
mechanism.
pH-Dependent E3 Kinetic Model 2995binding affinities depending on the redox state of the enzyme. This possi-
bility is often assumed in ordered redox enzyme mechanisms, but it is
traditionally not incorporated into the model equations in the general
form we present here. Binding polynomials for all substrates, products,
and protons as they may depend on redox state of the enzyme are shown
below.
Dh ¼

1þ H
þ
KH1

1þ H
þ
KH2

;
D1a ¼ 1þ A
KA1
þ P
KP1
;
D1b ¼ 1þ B
KB1
þ Q
KQ1
;
Dð2;3Þa ¼ 1þ A
KA2;3
þ P
KP2;3
;
Dð2;3Þb ¼ 1þ B
KB2;3
þ Q
KQ2;3
;
D4a ¼ 1þ A
KA4
þ P
KP4
;
D4b ¼ 1þ B
KB4
þ Q
KQ4
(2)
The binding polynomials represent all possible combinations of bound
and unbound binding sites and are used to calculate the fractional occu-pancy of each state bound with substrate and product. The fractional occu-
pancies (f) for each substrate and product are shown below; the subscript
and superscript terms indicate what substrates or products are being repre-
sented, and subscript numbers identify the enzyme redox state bound as
described above. The equilibrium dissociation constants for the proton-
binding sites are represented by KH1 for the thiolate and KH2 for the
active-site base.
fA1 ¼

A
KA1

D1a
; fA2;3 ¼

A
KA2;3

Dð2;3Þa
;
f H
þ
B2;3
¼

B
KB2;3

Dð2;3Þb

Hþ
KH2

Dh
; f H
þ
B4
¼

B
KB4

D4b

Hþ
KH2

Dh
;
f H
þ
P2;3
¼

P
KP2;3

Dð2;3Þa

Hþ
KH2

Dh
; f H
þ
P4
¼

P
KP4

D4a

Hþ
KH2

Dh
;
fQ1 ¼

Q
KQ1

D1b
; fQ2;3 ¼
 
Q
KQ2;3
!
Dð2;3Þb
:
(3)
The fractional occupancies are then used to write the kinetic equations that
govern the transitions between the three major enzyme states of the model.
The equations are shown in matrix form in Eq. 4 and were solved analyti-
cally by computing the pseudoinverse of the state-transition matrix using
MATLAB (2011b) Symbolic Math Toolbox, where S1, S2,3, and S4 repre-
sent the major enzyme steady-state concentrations and Et represents the
total enzyme concentration.Biophysical Journal 107(12) 2993–3007
2
666664


fA1k1 þ fQ1k4

Hþ
 
f H
þ
B2;3
k3 þ f HþP2;3k2

0
fA1k1 þ fQ1k4

Hþ
 f HþB2;3k3 þ f HþP2;3k2 þ fQ2;3k8Hþþ fA2;3k5 f HþB4 k7 þ f HþP4 k6
0

fQ2;3k8

Hþ
þ fA2;3k5 f HþB1 k7 þ f HþP1 k6
1 1 1
3
777775
2
4 S1S2;3
S4
3
5 ¼
2
664
0
0
0
Et
3
775 (4)
2996 Moxley et al.The net flux (J) of NADH, which is the major signal in the data sets, is ex-
pressed by considering the reactions that produce and consume it. The so-
lution to Eq. 4 is then used to compute J.J ¼ Et

½S2;3f HþB2;3k3  ½S1fQ1k4

Hþ
þ ½S4f HþB4 k7  ½S2;3fQ2;3k8Hþ
¼
0
BBBBBBBB@
n1ABPþ n2AB2PQþ n3AB2P
þn4AB2Qþ n5AB2 þ n6AB3P
þn7AB3 þ n8A2B2Qþ n9A2B2
þn10A2B3 þ n11ABQ2 þ n12ABQ
þn13A2BQ2 þ n14A2BQþ n15A2B
1
CCCCCCCCA

0
BBBBBBBB@
n16APQ3 þ n17APQ2 þ n18APQ
þn19BP2Q2 þ n20B2P2Qþ n21BP2Q
þn22BPQ2 þ n23BPQþ n24B2PQ
þn25ABPQ2 þ n26ABPQ þ n27P2Q
þn28P2Q2 þ n29PQ2 þ n30PQ3 þ n31P2Q3
1
CCCCCCCCA
d1A2 þ d2Q3 þ d3B3 þ d4B2 þ d5Q2 þ d6P2 þ d7BP2Q2 þ d8B2P2Qþ d9BP2Qþ d10BPQ2
þd11BPQþ d12B2PQþ d13ABPQ2 þ d14ABPQ þ d15ABPþ d16AB2PQþ d17AB2P
þd18AB2Qþ d19AB2 þ d20AB3Pþ d21AB3 þ d22A2B2Qþ d23A2B2 þ d24A2B3
þd25APQ3 þ d26APQ2 þ d27APQþ d28ABQ2 þ d29ABQþ d30A2BQ2 þ d31A2BQ
þd32A2Bþ d33A2Qþ d34A2Q3 þ d35QPþ d36QBþ d37QB2 þ d38Q2Bþ d39AP
þd40ABþ d41P2Bþ d42P2B2 þ d43PBþ d44PB2 þ d45P2B3 þ d46PB3 þ d47A2Q2
þd48AQþ d49AQ2 þ d50AQ3 þ d51P2Qþ d52P2Q2 þ d53PQ2 þ d54PQ3 þ d55P2Q3
(5)The expression for J is represented in coefficient form (36), using Maple 14
software (Maplesoft, Waterloo, Ontario, Canada), and contains 31 numer-
ator (n) and 55 denominator (d) terms when the proton concentration terms
are hidden in the coefficients for brevity. The analytical solutions of the
model equations reveal higher-order terms in both the numerator and de-
nominator, which was expected, considering that substrates and products
are able to bind multiple times in the mechanism (37). Higher-order terms
in the flux expression have the potential to produce so called non-Michaelis-
Menten behavior (hyperbolic deviation), which alters the definition of the
steady-state constants (37). Despite this, we derived and calculated the
apparent Michaelis-Menten constants and the forward and reverse kcat
based on their traditional mathematical definitions (32,38) from fitted rate
and equilibrium constants as a function of pH. This procedure was carried
out using MATLAB (2011b) Symbolic Math Toolbox according to a previ-
ously described protocol that implemented Maple symbolic software (38).
These results are reported in the Supporting Material.Model constraints
Thermodynamic loop constraints were derived as follows from the model
scheme in Fig. 1 C. From the left loop in Fig. 1 C,Biophysical Journal 107(12) 2993–3007S1#
fA1 k1
fH
þ
P2;3
k2
S2;3: (6)
At equilibrium, according to detailed balance,
Hþ½S1 fA1k1  ½S2;3fP2;3k2 ¼ 0 (7)
After rearranging,fA1k1
f H
þ
P2;3
k2
¼ ½S2;3½S1 : (8)
In a similar way, fromS2;3#
fH
þ
B2;3
k3
fQ1k4½Hþ
S1; (9)
f H
þ
B2;3
k3 ½S1fQ1k4½Hþ ¼ ½S2;3: (10)
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fA1k1f
Hþ
B2;3
k3
f H
þ
P2;3
k2fQ1k4½Hþ
¼ 1: (11)
Substituting the fractional occupancies from Eq. 2, 

k1k3
k2k4


A
KA1

D1a
B
KB2;3
D2;3b

Hþ
KH2

Dh
Hþ
KH2

Dh

P
KP2;3

D2;3a

Q
KQ1

D1b
Hþ
¼ 1: (12)
Rearranging yields the constraint   
k1 ¼ k2k4
k3
KA1 KB2;3
KP2;3 KQ1
D1a D2;3b
D2;3aD1b
Keq (13)
The overall equilibrium constant, expressed in Eq. 14, was normalized to
pH 7 by multiplying the righthand side of Eq. 14 by 107.Keq ¼ PQH
þ
AB

eq
: (14)
The same reasoning applies to the second loop in the overall reaction and
yields the constraintk5 ¼

k6k8
k7
 
KA2;3 KB4
KP4KQ2;3
!
D2;3a D4b
D4aD2;3b

Keq: (15)
The midpoint potentials (Em) at pH 7 and 25
C for the Lipo/DHL and
NADþ/NADH couples are 0.287 and 0.320 V, respectively (2,26). We
used these midpoint potentials to calculate an overall equilibrium constant
(Keq) of 0.0766:
Keq ¼ enFDEmRT ; (16)
where n is the number of electrons transferred, F is Faraday’s constant
(96,485 C mol1), DE is the midpoint potential difference, R is the gasm
constant (8.315 J K1 mol1), and T is the temperature in Kelvin. The over-
all equilibrium constant was fitted for each data set (collected at 25C)
within a twofold range of 0.0766 using Eqs. 13 and 15. We applied a soft
equilibrium constraint, since midpoint potentials can vary depending on
the methods used to determine them (39), and this variability is amplified
due to the exponential relationship between DEm and Keq shown in
Eq. 16. The twofold variation in Keq assumes that the error in the reported
potentials is <1.5%. Notably, it was determined that it is possible to fit the
data from all organisms at 25C with values of Keq within a narrow range of
0.0383 to 0.05. However, because the rat liver data set was collected at 37C
(22), we allowed this Keq to vary beyond a twofold range.Model fitting
Data were fitted using MATLAB 2011b software (The MathWorks, Natick,
MA) using customized code of either a simulated annealing or genetic
algorithm. They were then further optimized using the local nonlinear opti-
mization function FMINCON. When data sets contained time-dependent
data, the rate equations for A, B, P, and Q derived from the steady-state
solution (solution to Eq. 4) were integrated using the numerical integrator
ode45 (Runge-Kutta algorithm) in MATLAB and fitted simultaneously
with initial rate data. Alternatively, the full solution (no steady-stateassumption (40)), which contains time-dependent solutions of S1, S2,3,
and S4 using ode15s (a stiff solver in MATLAB) were also used to fit the
data. Despite the added sophistication of the latter method, we did not
see any improvement in fitting. Therefore, all results are shown using the
former method. Data sets were obtained from previous publications
(11,13,22,23,41,42) using the freely available graph digitizing software
ScanIt 1.06 (amsterCHEM). As errors were not given for any of the pub-
lished data sets, the cost function (or error/fitting function) was weighted
according to a general 10% error assumption as described previously
(35). The extracted literature data andMATLAB code required to reproduce
the figures in the main text and Supporting Material are included in the Sup-
porting Material. It is important to note that data sets from each organism
were fitted simultaneously, or globally, as compared to fitting individual
data sets, the traditional approach to enzyme kinetic analysis (43,44).
Each data set was fitted allowing all equilibrium dissociation constants to
be either independent of or dependent on the redox state of the enzyme.
This added sophistication in the model was implemented in an effort to bet-
ter fit more expansive data sets, such as the E. coli and the spinach E3 data
sets described below. Data sets such as the rat and human liver did not
require the more detailed redox-dependent Kd model to fit the data.
In an effort to obtain the best fit, multiple fitting trials were conducted
using the algorithms mentioned above (including global optimization)
with random initial starting points. Fit results that fell within a certain
cost-function value were saved (~100 fits), and parameter values and their
ranges were tabulated. This process gives insight into parameter uncertainty
by showing parameter variation while still fitting the data. Results for this
fitting procedure are displayed in the Supporting Material.RESULTS AND DISCUSSION
To our knowledge, Massey was the first to conclude that E3
from pig heart followed ping-pong-type kinetics based on
LB plot analysis (1). Others have argued that this enzyme
may also proceed via a ternary mechanism (25,45), and
recent structural data clearly show that two distinct sites
are required to react with lipoyl and pyridine nucleotide sub-
strates (4). An extensive steady-state kinetic data set with
the rat liver enzyme, collected by Reed (22), offers a suit-
able challenge for our model through global fitting. Most
enzyme kinetic studies lack proper global fitting analysis,
which requires consistency among all data sets; therefore,
we emphasize that this type of fitting procedure was imple-
mented in fitting all of the data sets to our model.
The data set collected by Reed includes initial velocity
substrate profiles in the forward (Fig. 2 A) and reverse
(Fig. 2 B) directions, as well as product-inhibition (Fig. 2,
C–F) and pH-dependent (Fig. 2 G) data. In the analysis,
Reed concluded that a simple ping-pong-type mechanism
was not able to describe the observed product inhibition
patterns (22). Although if lipoamide and NADH were
considered to bind the oxidized and reduced forms of the
enzyme, respectively, this would create LB patterns consis-
tent with the data (22). Although it explains LB patterns, the
model by Reed fails to account for the reversibility of the
NADH inhibition step by NADþ based on the active-site
chemistry, assumes one binding site for both substrates
and products (which is inconsistent with structural data
(4,46,47)), and completely neglects any modulation of the
reaction by pH, which is crucial for the regulation of thisBiophysical Journal 107(12) 2993–3007
FIGURE 2 Global fitting of rat liver E3 activity
as a function of substrates, products, and pH to data
from Reed (22) (see Supporting Material). In all
cases, the data are represented by symbols and
the model by solid lines. (A) Initial velocity data
in the absence of products in the forward direction,
collected by varying NADþ in different fixed con-
centrations of dihydrolipoamide (DHL) (top to
bottom: 3, 0.5, 0.2, and 0.1 mM) at pH 8 were ob-
tained from Fig. 1 A of Reed (22). (B) Initial veloc-
ity data in the absence of products in the reverse
direction, with NADH varied and different fixed
lipoamide concentrations (top to bottom: 1.62,
0.81, 0.54, and 0.36 mM) were obtained from
Fig. 1 B of Reed (22). (C) Initial velocity data in
the forward direction with DHL varied in a high
NADþ concentration (4.2 mM) with different fixed
NADH (top to bottom: 0, 0.108, 0.216, and
0.324 mM) at pH ¼ 8 were obtained from Fig. 3
of Reed (22). (D) Initial velocity data in the for-
ward direction with DHL varied in low NADþ con-
centration (0.52 mM) with different fixed NADH
concentrations (top to bottom: 0, 0.108, 0.216,
and 0.324 mM) at pH 8 were obtained from
Fig. 4 of Reed (22). (E) Initial velocity data in
the forward direction at high DHL concentration
(5 mM) with different fixed NADH (top to bottom:
0, 0.11, 0.23, and 0.34 mM) at pH 8 were obtained
from Fig. 5 of Reed (22). (F) Initial velocity data in
the forward direction at low DHL (0.5 mM) in
different fixed concentrations of NADH (top to
bottom: 0, 0.11, 0.23, and 0.34 mM) at pH 8
were obtained from Fig. 6 of Reed (22). (G)
Log10(Vmax) of the forward reaction with pH ob-
tained from Fig. 9 of Reed (22). To see this figure
in color, go online.
2998 Moxley et al.enzyme (Fig. 2 G). Furthermore, this enzyme is capable of
producing product from either of two pathways shown in
Fig. 1 C. Globally fitting the rat liver enzyme data (22) to
the Kd redox-independent model demonstrates that the
model can consistently explain all of the data, including
the pH dependence of Vmax while being constrained by
the known equilibrium constant and thermodynamic loop
constraints.
E. coli E3 is an example of an E3 that is strongly regu-
lated by the NADþ/NADH ratio (11). As E3 is a component
of the PDH complex, increased sensitivity to the NADþ/
NADH ratio is thought to be important for compensating
for the lack of regulation by phosphorylation of the E. coli
PDH complex (12), which is present in mammalian PDH
complexes (18). The enzyme’s sensitivity to the NADþ/Biophysical Journal 107(12) 2993–3007NADH ratio is demonstrated by a number of experiments
conducted by Wilkinson and Williams (11).
A substantial lag in progress curves has been observed in
the reverse direction (Fig. 3, A and B) when NADH and lip-
oamide are utilized as substrates without initially added
NADþ (3,11). The severity of this lag is modulated by
both NADþ and pH (Fig. 3, A and B). The lag is abated
by either increasing initial amounts of NADþ or increasing
the pH (Fig. 3, A and B). This phenomenon was observed
with pig heart E3 by Massey (24), who hypothesized that
a four-electron-reduced dead-end state was responsible.
The E. coli E3 data set from Wilkinson and Williams repre-
sents, among dihydrolipoamide dehydrogenases in general,
one of the larger kinetic data sets displaying NADH inhibi-
tion that is rescued by added NADþ (Fig. 3, A and D–F)
FIGURE 3 Global fitting of the E. coli E3 progress curve, substrate inhibition, NADþ activation, and pH-dependent data obtained from previous studies
(3,11,42) (see Supporting Material). All data (symbols) were fitted to two models, where the Kd for substrates and products was either independent (solid
lines) or dependent (dashed lines) on the enzyme redox state, as described in Methods. (A) Progress curves for the reverse reaction (pH 7.9) in different
NADþ concentrations, with data obtained from Fig. 1 of Wilkinson and Williams (11). (B) Progress curves for the reverse reaction, with pH varied, with
data obtained from Fig. 5 of Koike et al. (3). (C) Progress curves in the forward direction with pH varied, with data obtained from Fig. 4 of Koike et al.
(3). (D) Initial velocity divided by total enzyme concentration (v0/Et) in the reverse direction (pH 7.9) with varied NADH with different fixed NAD
þ con-
centrations. Data were obtained from Fig. 6 of Wilkinson and Williams (11). (E) Activation of reverse v0/Et (pH 7.9) with increasing NAD
þ concentration,
with data obtained from Fig. 3 of Wilkinson and Williams (11). (F) v0/Et as a function of pH and NAD
þ concentration, with data obtained from Fig. 2 of
Wilkinson and Williams (11). (G) Forward kcat as a function of pH, with data obtained from Fig. 4 A of Sahlman and Williams (42). (H) v0/Et as a function of
NADþ concentration (pH 6.05), with data obtained from Fig. 2 of Sahlman and Williams (42). To see this figure in color, go online.
pH-Dependent E3 Kinetic Model 2999(11). To incorporate data in the forward direction, including
forward pH-dependent data (Fig. 3, C and G), we added
E. coli E3 data from Sahlman and Williams (42) and Koike
et al. (48) (Fig. 3, C, G, and H).
The E. coli E3 data (11,42,48) were then globally fitted to
the redox-independent (Fig. 3, solid lines) and redox-depen-
dent (Fig. 3, dashed lines) Kd model. Fitting the E. coli data
set illustrates that both the simpler and more complex
models can capture all major features of the E. coli data;
however, the more detailed model improves the fitting of
the data, especially in Fig. 3 D. The E. coli initial-velocity
pH-dependent data in Fig. 3 F reveal an interesting shift
in the optimum pH from a basic to an acidic pH when
NADþ is added to the initial reaction mixture. This phenom-
enon can only be predicted by a model that accounts for the
reversibility of the NADH inhibition by NADþ. In addition,
the recovery of activity in the reverse direction by additionof NADþ is predicted (Fig. 3 F). The model also predicts
that activation by NADþ (Fig. 3 E) will saturate and has
the potential to inhibit at high enough NADþ concentra-
tions, depending on the parameterization of the model.
Thus, our model can treat NADþ as a partial activator or
inhibitor (32,37) when the net flux is favored in the reverse
direction. Even though the simpler model can describe the
major features of the data, the degree of inhibition/activation
of NADþ is more accurately described by the more detailed
model (Fig. 3, D and E).
To explain their data, Wilkinson and Williams put forth a
mechanistic hypothesis that included a model similar to
that of Reed, discussed above (11). Their proposed model
adds the possibility of NADþ binding to the oxidized
enzyme form (observed previously (25)) while excluding
the possibility of lipoamide forming a dead-end complex
with the oxidized enzyme form (11). In contrast to ReedBiophysical Journal 107(12) 2993–3007
3000 Moxley et al.(22), they do discuss effects of NADH reducing the two-
electron-reduced enzyme state into the four-electron-
reduced state (11). The method they used to test their
model was again reasoning of LB plot patterns based on
fitting individual data sets that may lack global parameter
consistency (11). In addition, no parameters were even re-
ported, so no information is available within the context of
this publication to reproduce a model for E. coli E3 that
accurately describes the data (11). Their model (11),
although more advanced than that of Reed (22), also suf-
fers from lack of consideration of pH, which greatly dic-
tates the effects of the substrates and products on the
enzyme state (Fig. 3, B, C, F, and G) and its propensity
to catalyze the reaction in a preferred direction (Fig. 3, B
and C). Interestingly, Wilkinson and Williams argued that
the data shown in Fig. 3 H can be fitted significantly better
using a cooperative model than a basic Michaelis-Menten
model (see Fig. 2 in Sahlman and Williams (42)). A
notable aspect of our model is that it reveals that the
apparent cooperativity is an emergent property of the
enzyme mechanism (Fig. 1 C) and is a consequence of
higher-order terms in the steady-state expression (Eq. 5).
Segel (37) has discussed similar behavior of cooperative
and random mechanisms.
Similar observations made with E. coli E3 data have also
been observed with E3 from spinach (Fig. 4) (13). A signif-
icant lag is observed in reverse progress curves in the
absence of added NADþ (Fig. 4 A), although it is somewhat
less severe than with the E. coli enzyme (Fig. 3, A and B).
Similar to the E. coli enzyme, spinach E3 forward-progress
curve conditions that differ only in pH show an increase inBiophysical Journal 107(12) 2993–3007the apparent equilibrium constant as a function of pH
(Fig. 3 C). This behavior is consistent with the pH-depen-
dent equilibria of the Lipo/DHL and NADþ/NADH redox
couples, where the pH dependence of the apparent equilib-
rium constant is constrained by our model within a
twofold range of the equilibrium constant normalized to
Keq(pH 7) ¼ 0.0766 at 25C (see Model constraints).
The data set from spinach E3 (13) was then globally fitted
to the redox-independent (Fig. 4, solid lines) and redox-
dependent (Fig. 4, dashed lines) Kd model. The main devi-
ation when fitting to the simpler redox-independent model
occurs with the NADþ activation data (Fig. 4 D), in the
reverse direction, where the data show a tighter saturation
compared to the model; however, when the Kd(s) are
allowed to become dependent on the redox enzyme state,
the model can accurately describe these data (Fig. 4 D,
dashed lines). Other fits of the simpler model to the spinach
enzyme (see Fig. S8 in the Supporting Material) demon-
strate that the simpler model can accurately fit the data
shown in Fig. 4 D but at the cost of deviating from the
reverse-progress-curve data.
We also globally fitted a smaller data set available from
human liver E3 to the redox-independent Kd model
(Fig. 5) (23). An obvious difference between the human
liver data set and the other data sets that contain progress-
curve data is a much shorter observed lag in the reverse re-
action (Fig. 5 B) in the absence of initially added NADþ.
This difference can be explained by human liver having a
smaller fraction of the E3 enzyme concentration than
E. coli and spinach in the over-reduced dead-end state
(Fig. 1 C, S4). Previous investigators (11,23) have madeFIGURE 4 Global fitting of spinach E3 progress
curves, NADþ activation, and pH-dependent data
obtained from Matthews and Reed (13) (see Sup-
porting Material For data). All data (symbols)
were fitted to two models in which the Kd for sub-
strates and products was either independent (solid
lines) or dependent (dashed lines) of the enzyme
redox state, as described in Methods. (A) Prog-
ress-curve data for the reverse reaction in different
NADþ concentrations (pH 6.3), with data obtained
from Fig. 4 in Matthews and Reed (13). (B) Prog-
ress-curve data for the forward reaction with varied
pH, with data obtained from Fig. 7 of Matthews
and Reed (13). (C) Initial velocity of the reverse re-
action as a function of pH and NADþ concentra-
tion, with data obtained from Fig. 6 of Matthews
and Reed (13). (D) Activation of reverse initial
velocity with increasing NADþ concentration
(pH 6.3), with data obtained from Fig. 5 of Mat-
thews and Reed (13). To see this figure in color,
go online.
FIGURE 5 Global fitting of the human liver E3
progress curve and pH-dependent data from Ide
et al. (23) (see Supporting Material). (A) Prog-
ress-curve data for the forward reaction (pH 8.5),
with data obtained from Fig. 6 of Ide et al. (23).
(B) Progress-curve data for the reverse reaction
in different NAD concentrations (pH 6.5), with
data obtained from Fig. 4 of Ide et al. (23).
(C) Initial velocity as a function of pH for the for-
ward (squares) and reverse reactions (circles), with
data obtained from Fig. 5 of Ide et al. (23). To see
this figure in color, go online.
pH-Dependent E3 Kinetic Model 3001this qualitative conclusion to explain differences in the data,
and it is consistent with our model, as discussed below.
To address the apparent difference in the steady-state
redox enzyme state distributions of E3 components from
different organisms, we used a multitude of parameter sets
that fit the data (see Supporting Material) by means of
the simpler redox-independent Kd model to calculate the
enzyme fraction in each of the three major states
(Fig. 1 C) as a function of the oxidized and reduced lipoa-
mide (Lipo/DHL) and NAD ratio with pH and then
calculated their mean distribution (Figs. 6 and 7). The
greatest contrast is between the E. coli and human E3 dis-
tributions, as shown in the main text, whereas the spinach
E3 distribution, which is more similar to the E. coli E3 dis-
tribution, is shown in the SupportingMaterial (see Fig. S11).
We excluded the rat liver data set (Fig. 1) from the enzyme
steady-state distribution analysis, since this data set did not
contain progress-curve data, which includes information on
the lag phase. The lag-phase data provides information on
the S4 state population, which greatly influences the calcu-
lated steady-state distributions and subsequent conclusions.
The mean steady-state redox enzyme state distribution
calculated for E. coli E3 (Fig. 6) shows that at a low pH
and NADþ/NADH ratio the four-electron dead-end state
(S4) is much more populated relative to the others. At pH
6.5, with all NADþ/NADH and Lipo/DHL ratios shown in
Fig. 6, the four-electron-reduced dead-end state (S4) repre-
sents >97% of the total enzyme concentration, showing
the importance of pH in dictating this state.
The human liver E3 displays a shorter lag time compared
to the E. coli and spinach enzymes, even at a lower pH
(Fig. 5 B). To compare enzyme distributions, we also useda large parameter set that fits the human liver data (see
Fig. S12) to calculate the mean steady-state redox
enzyme-state distribution (Fig. 7). This calculation shows
that in general, the enzyme mainly exists in the S1, S2,3,
and S4 states at pH R 7, 5 % pH % 6.5, and pH % 5,
respectively. Although it appears that pH is the major regu-
lator of the enzyme states compared to the NADþ/NADH
ratio, it is important to remember that the pH is calculated
on a logarithmic scale and that each pH unit thus represents
a 10-fold change in proton concentration. Thus, changes
from pH 5 to 7 represent 100-fold changes in the hydrogen
ion concentration.
Overall, the progress-curve lag phase for the E. coli
(Fig. 3, A and B), spinach (Fig. 4 A), and human liver
(Fig. 5 B) E3 data sets vary substantially. Analysis of the
mean steady-state redox enzyme-state distributions is
consistent with the hypothesis that the underlying kinetic
differences between these enzymes are indicative of their
propensity to be driven into the four-electron-reduced state
(S4). Even though most E3 enzymes have about a 40%
sequence homology (54), differences in the progress-curve
lag phases cannot be explained using a single parameter
set. However, as we have shown here, all of the kinetic
data can be explained by a single mechanism.
Analysis of recent structural data does not give a clear
explanation for kinetic differences among E3 homologs
because active sites between homologs are conserved (54).
However, there do not appear to be definitive structures of
the four-electron-reduced state (S4), which may reveal
more information on regulatory differences. Structure-based
kinetic predictions have shown that accounting for molecu-
lar fields such as the electrostatic potential is imperative forBiophysical Journal 107(12) 2993–3007
FIGURE 6 Mean E. coli E3 major redox steady-state distributions. E. coli E3 major redox steady-state distributions calculated from 100 parameter sets
(see Supporting Material) with the redox-independent Kd model and Lipo/DHL and NAD
þ/NADH ratios as a function of pH. NADþ/NADH ratios were
chosen based on literature data collected in aerobic conditions, and Lipo/DHL ratios were arbitrarily chosen (49). Total concentrations of lipoamide and
NAD species were set to 10 mM and 3 mM, respectively. The total lipoamide concentration is based on a millimolar range approximation of the stoichiometry
and volume of the pyruvate dehydrogenase complex (5). The total concentration of NAD species was chosen to compare with human liver state distribution
calculations (Fig. 7). Note that plots in the S4 column have been rotated with respect to those in other columns for a better view of the smaller bars, which
would otherwise be hidden. To see this figure in color, go online.
3002 Moxley et al.accurate prediction of simple steady-state kinetic parame-
ters (55). E3s from various sources have been shown to
vary in redox potential (see Table 2 of Argyrou et al.
(33)). These variations in redox potential are consistent
with differences in active-site electrostatic potentials,
which then may explain some of the observed kinetic
discrepancies.
Best-fit parameters and local sensitivity coefficients for
each of the data sets are shown in Table 1. For more compli-
cated data sets, such as E. coli and spinach, parameter values
are given for additional Kd(s) that represent different
enzyme redox states, as described above. In our attempts
to fit each data set, we collected ~100 fits from random start-
ing points that fell within a certain cost function cutoff value
(fval) with respect to the best fit (Figs. S1, S6, S9, and S13).
The results for this trial typically show that a wide range ofBiophysical Journal 107(12) 2993–3007parameter values can fit these data sets, so the values shown
in Table 1 are not well bounded by the data sets. Low con-
fidence is expected for rate constants as compared to equi-
librium dissociation constants, since the data used to fit
the model are of the steady-state type and little information
is available on the time dependency of enzyme states (56);
however, rate constants can be calculated for certain simple
mechanisms (32,36,37).
To analyze correlations between parameters, we con-
structed scatter plots of each parameter pair from the inde-
pendently estimated set of parameter values. For the
redox-independent Kd model, this exercise yields 105
different combinations of parameters (Figs. S2, S7, S10,
and S14). This analysis explicitly shows linear and
nonlinear relationships for each of the E3 parameter sets.
Of the 127 fits to the rat liver E3 data set, three distinct
FIGURE 7 Mean human liver E3 major redox steady-state distributions as a function of pH, lipoamide, and NAD oxidized and reduced ratios calculated
from 70 different parameter sets that fit the data (see Supporting Material). Human liver E3 major state distributions were calculated from 70 parameter sets
from the redox-independent Kd model and Lipo/DHL and NAD
þ/NADH ratios as a function of pH. NADþ/NADH ratios were chosen based on literature data
estimating a typical range of NADþ/NADH (50–52) and Lipo/DHL ratios were arbitrarily chosen. Total concentrations of lipoamide and NAD species were
set to 10 mM and 3 mM (53), respectively. The total lipoamide concentration is based on a millimolar range approximation of the stoichiometry and volume
of the pyruvate dehydrogenase complex (5). To see this figure in color, go online.
pH-Dependent E3 Kinetic Model 3003parameter families were identified (Table S1). Since the
estimates cluster into these three families, it is difficult to
identify trends in the parameter scatter plots for the rat liver
E3 parameter sets (Fig. S2). To better analyze correlations
between rat liver E3 parameter sets, we computed correla-
tion matrices (Fig. S3) for the average of three families of
parameters that describes the overall parameter set (Table
S1). These matrices demonstrate mostly moderate param-
eter correlation (average coefficients of 0.6 or 0.6 or
less). In general, correlation was seen between parameters
comprising the same mechanistic loop, such as k1 through
k4, and between substrate and product equilibrium dissoci-
ation constants.
Despite variability and correlation in the parameters, the
mean steady-state distributions of the enzyme redox states
(Figs. 6 and 7) represent more stable pieces of informationthat can be extracted from these data. These distributions
were calculated from all of the parameter sets we found
that fit the data (see Supporting Material). Parameter values
that change within a wide range but still fit the data in a
similar way (see Supporting Material) still produce similar
steady-state distributions of the different redox enzyme
states. This is indicated by a low percent coefficient of vari-
ation for enzyme states that represent >80% of the total
enzyme concentration (Fig. S16). We also intuit that fitting
larger data sets that contain more information leads to less
variable predictions of enzyme redox steady-state distribu-
tions (Fig. S16).
A major goal of our kinetic analysis was to constrain the
fitting using a known value (0.0766) for the overall equilib-
rium constant at 25C and pH 7 (2). We allowed this value to
vary within a small range to account for differences in ionicBiophysical Journal 107(12) 2993–3007
TABLE 1 Best-fit examples of kinetic parameters for dihydrolipoamide dehydrogenase from various organisms
Parametera
Rat liver enzyme Human liver enzyme E. coli enzyme Spinach enzyme
Single Kd
set Sensitivityb
Single Kd
set Sensitivityb
Single Kd
set
Multiple Kd
set Sensitivityb
Single Kd
set
Multiple Kd
set Sensitivityb
k1 (min
1)c 4.05  104 — 1.26  107 — 1.11  109 — — 2.78  107 — —
k2 (min
1) 294 0.183 9.91  104 0.349 2.76  104 2.52  104 0.393 (0.727) 3.17  106 1.95  105 0.308 (1.04)
k3 (min
1) 2.56  104 0.103 1.06  104 0.176 1.32  104 9.76  104 0.0518 (0.138) 103 106 0.184 (0.135)
k4 (min
1) 107 0.127 8.64  105 0.186 1.25  106 2.38  106 0.0905 (0.111) 6.33  103 5.86  103 0.255 (0.294)
k5 (min
1)c 1.22  104 — 1.15  105 — 2.49  106 — — 3.42  105 — —
k6 (min
1) 5.56  103 0.538 103 8.62  104 70.2 581 0.218 (0.2) 103 1.47  103 0.670 (0.128)
k7 (min
1) 1.33  105 0.236 4.97  106 0.0212 1.21  105 1.52  106 0.430 (0.676) 2.60  104 3.85  103 0.520 (0.901)
k8 (min
1) 8.30  105 0.371 3.69  104 0.0213 107 8  106 0.389 (0.696) 6.43  106 5.0  104 0.487 (0.950)
pKh1
(thiolate)
6.98 0.044 7.32 0.349 7.5 7.34 0.399 (0.566) 5.67 4 0.297 (0.01)
pKh2 (base) 9 0.042 9 0.0281 8.56 8.85 0.193 (0.14) 9 8.9 0.030 (0.017)
KA1 (mM) 920 0.307 2.5  103 1.15  104 104 104 103 (1.2 
1017)
155 4.88 0.040
(6.4  1018)
KB1 (mM) 1.74  103 0.388 1.1 0.177 498 498 0.439 (5.6 
103)
2.70 2.55 0.361 (0.163)
KP1 (mM) 758 0.657 1.15 0.002 3.44 3.44 0.01 (5.6 
1018)
3.26 33.3 0.0393
(6.4  1018)
KQ1 (mM) 1.24  103 0.487 70.5 0.18 520 520 0.370 (0.11) 3.55 1 0.338 (0.166)
KA2,3 (mM) — — — — — 55.6 9.9  104 — 5.05  103 0.0105
KB2,3 (mM) — — — — — 1.04  103 0.115 — 26.2 0.0701
KP2,3 (mM) — — — — — 1.67 0.254 — 19.6 0.0320
KQ2,3 (mM) — — — — — 429 0.604 — 1 0.0654
KA4 (mM) — — — — — 1.58 0.125 — 1 0.0610
KB4 (mM) — — — — — 230 0.683 — 26.6 0.380
KP4(mM) — — — — — 2.8  103 0.276 — 104 0.111
KQ4 (mM) — — — — — 1.63 0.680 — 10
4 0.0028
Keq (pH 7) 0.206
d 0.734 0.0418 0.0696 0.153 0.103 0.168 (0.667) 0.0383 0.0446 0.302 (0.115)
aRate constants were constrained within the range 103 to 109 min1 and equilibrium dissociation constants within the range 1 to 104 mM. pKh1 and 2 were
generally in the range between 4 and 9.
bSensitivities were calculated according to a previously described method (35); sensitivities in parentheses correspond to multiple Kd fits.
cParameter was solved for based on thermodynamic cycle constraints.
dRat liver enzyme data were collected at 37C (22); thus, the equilibrium constant for these data was allowed to vary more from its known value at 25C
compared to the other data sets, which were collected at 25C.
3004 Moxley et al.strength and midpoint potential uncertainties. For example,
a change of 1.5% in the midpoint potentials results in a
twofold change in the equilibrium constant. To maintain a
more consistent overall equilibrium constraint for all data
sets collected at 25C, which include the E. coli, spinach,
and human liver data sets, we showed that we can fit these
data sets within the narrow range of 0.0383 to 0.05 (Table 1).
Although values of 0.153 and 0.103 are shown in Table 1 for
the E. coli best-fit examples of the redox-independent (sin-
gle Kd) and redox-dependent (multiple Kd) models, respec-
tively, further fitting and constraining of the equilibrium
constant shows that these data can be well fitted with values
of 0.05 and 0.048 for each of these respective models
(Fig. S5).
Definitions of steady-state constants in terms of rate and
equilibrium dissociation constants were also derived using
their typical mathematical definitions (32). The most widely
used method for deriving steady-state constants as functions
of microscopic rate constants and equilibrium dissociation
constants for enzymatic reaction mechanisms is that of
Cleland (36,37). However, discussion of this method hasBiophysical Journal 107(12) 2993–3007not been extended to include complex reaction mechanisms
that create numerous high-order terms in the denominator of
the flux expression (see Eq. 5) (37). Typically, when this sit-
uation is confronted, attempts are not made to define steady-
state constants (37).
Despite this, to further analyze our mechanism, we used
MATLAB (2011b) Symbolic Math Toolbox to derive the
steady-state-constant definitions in a manner similar to
that of Straathof et al. (38). The MATLAB code for this pro-
cedure is provided in the Supporting Material. Steady-state
parameters for the redox-independent Kd mechanism were
calculated for rat liver, E. coli, spinach, and human liver
E3 using all of approximately 100 parameter sets that fit
each dataset (Figs. S3, S7, S10, and S14). The steady-state
parameters are a function of pH, and they can vary substan-
tially when there is a large parameter range that fits the data
(Figs. S4, S8, S11, and S15). The calculated steady-state pa-
rameters for the rat liver (Fig. S4) and E. coli (Fig. S8) E3
parameter sets were less variable than the spinach
(Fig. S11) and human liver (Fig. S15) E3 parameter sets.
For the rat liver data, this is probably due to the fact that
pH-Dependent E3 Kinetic Model 3005the data can be fit by three distinct families of parameters
(Table S1). In addition, the experiments conducted with
rat liver E3 contain more information on these parameters
since they assay a wider range of substrate and product
concentrations.
In general, the calculated reverse kcat is low relative to the
typical kobs or v0/Et (Figs. S4, S8, S11, and S15). This is
because kcat is defined in the limit of substrates approaching
infinity and is not a true maximum in flux (32). Since sub-
strate inhibition is observed with NADH (Fig. 3 D), as the
NADH concentration approaches infinity the catalytic rate
is partially inhibited (36)); this issue has been pointed out
previously with regard to E3 (57). Optimization of the
flux expression to obtain an actual flux maximum may be
a more appropriate and possibly a more physiologically
relevant enzyme kinetic analysis.CONCLUSIONS
Several independent kinetic sets of data on the E3 compo-
nent from various organisms, including rat, E. coli, spinach,
and human, were globally fitted to a pH-dependent model
that accounts for a well-documented description of the
active-site chemistry found in the literature. This model is
able to reproduce a number of unique characteristics of
the kinetic data sets, including NADþ-dependent pH op-
tima, NADþ/NADH-dependent activation/inhibition, and
NADþ/pH-dependent progress-curve lags. Although it is
consistent with previous hypotheses that an over-reduced
four-electron dead-end state is responsible for the unique
regulation of this enzyme, the model now provides a quan-
titative means of simulating this behavior spanning three
kingdoms of life.
The model incorporates active-site proton binding sites,
such as an active-site base and thiolate, that are critical
for pH regulation of its catalytic mechanism, and it provides
a template for integrating these general features into
other FAD-containing disulfide oxidoreductase enzymes
(19,26,30). The model accounts for the possibility of the
effect of redox-dependent binding of substrates and prod-
ucts to more accurately account for redox-related phenom-
ena not well captured by simpler mechanisms. Moreover,
NADþ/NADH-dependent enzymes are ubiquitous in redox
metabolism and will be affected by pH in a similar manner.
Therefore, to support efforts to model other enzymes,
ranging from disulfide oxidoreductases to NADþ/NADH-
dependent enzymes, we have supplied the model code in
the Supporting Material. General MATLAB code has also
been supplied in the Supporting Material for handling the
derivation of steady-state constants for bi-bi reaction mech-
anisms (and easily adaptable to others).
Here, we also provide to our knowledge, a novel and
rigorous demonstration that shows although the set of param-
eters that fit the data is large, all parameters predict similar
enzyme redox steady-state distributions. This demonstrationis to our knowledge unprecedented. Furthermore, this distri-
bution calculation provides useful information that is not
typically gleaned from steady-state-type data. Here we
have used a range of what could be physiological or patho-
physiological conditions to calculate steady-state redox
enzyme distributions to predict the redox state of E3 during
potential in vivo conditions. Therefore, in vitro quantitative
knowledge of enzyme behavior and mechanism can be
used to better quantitatively understand more elusive in vivo
metabolic states.
Moreover, E3 is a component of the PDH complex,
providing a layer of its regulation by sensing changes in
the NADþ/NADH ratio, which in turn imparts regulation
of central metabolism (6,9,14). Therefore, we look to incor-
porate this accurate E3 model into a larger multicomponent
model of the PDH complex that will in turn provide better
predictions of NAD ratio and pH effects on PDH-complex
kinetic regulation. A detailed kinetic model of PDH-com-
plex regulation that accounts for its individual components
will yield a better quantitative understanding of the kinetic
regulation of central metabolism.SUPPORTING MATERIAL
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